Sopharma AD reported a 23% decline in sales for July 2025 compared to the same month last year. The company stated that domestic sales fell by 25%, while export sales dropped by 22%.
Despite this monthly decrease, Sopharma noted that from the beginning of 2025, overall sales increased by 4%. This result was due to a 6% decrease in domestic sales being offset by a 12% increase in export sales.
According to the company: “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for July 2025 the Company recorded decrease in sales of 23% compared to the same month of the previous year, incl. 25% decrease in domestic sales and 22% decrease in export sales.
For the period from the beginning of 2025, the Company realized a 4% increase in sales, including 6% decrease in domestic sales and a 12% increase in export sales.
